The board of Arix Bioscience plc appointed James Noble and Axel Wieandt as non-executive directors of the company. Whilst the board continues to believe that both appointees are highly qualified with relevant experience and expertise, it believes the appointments should be considered within the scope of the company's recently announced Strategic Implementation Review, (the "Review") which includes the question of board composition.